Abstract
Purpose
Mycobacterial periprosthetic joint infection (PJI) is very rare and is generally associated with an immunosuppressive environment. Few large-scale studies of this unusual PJI have been conducted. The current study was performed to assess the clinical features and outcomes following two-stage re-implantation for mycobacterial PJI after primary total knee arthroplasty (TKA).
Methods
We conducted a retrospective review of data collected from our database involving ten cases of two-stage re-implantation manifesting mycobacterial PJI. Patients were followed for at least five years or until recurrent infection. The mean follow-up duration in patients who remained free of infection was 7.5 years (range 5–9.5 years).
Results
Seven patients (70%) belonged to the American Society of Anesthesiologists’ grade 3 or 4. The surgical protocol entailed resection arthroplasty and cement spacer insertion with vigorous debridement, followed by at least six weeks of systemic antimicrobial therapy and delayed re-implantation in all patients. The median duration from resection arthroplasty to re-implantation was 5.3 months (range 2–10.5 months). Following re-implantation, five patients with Mycobacterium fortuitum were treated with amikacin for six weeks and oral clarithromycin for three months. Five patients infected with M. tuberculosis received anti-tuberculosis medications immediately after pathogen isolation, for a period of 12 months.
Conclusion
Mycobacterial PJI can be treated successfully via resection arthroplasty and delayed re-implantation combined with proper antimicrobial agents. Suspicious infection or loosening after primary TKA, particularly in an immunosuppressive environment, warrants the attention of an orthopedic surgeon to consider the possibility of unusual PJI.
Similar content being viewed by others
References
Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J (2008) Infection burden for hip and knee arthroplasty in the United States. J Arthroplast 23(7):984–991
Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Osmon DR (1998) Prosthetic joint infection due to Mycobacterium tuberculosis: a case series and review of the literature. Am J Orthop 27(3):219–227
Carrega G, Bartolacci V, Burastero G, Finocchio GC, Ronca A, Riccio G (2013) Prosthetic joint infections due to Mycobacterium tuberculosis: a report of 5 cases. Int J Surg Case Rep 4(2):178–181
Harwin SF, Banerjee S, Issa K, Kapadia BH, Pivec R, Khanuja HS et al (2013) Tubercular prosthetic knee joint infection. Orthopedics 36(11):e1464–e1469
Hecht RH, Meyers MH, Thornhill-Joynes M, Montgomerie JZ (1983) Reactivation of tuberculosis infection following total joint replacement: a case report. J Bone Joint Surg Am 65(7):1015–1016
Herold RC, Lotke PA, MacGregor RR (1987) Prosthetic joint infections secondary to rapidly growing Mycobacterium fortuitum. Clin Orthop Relat Res 216:183–186
Klein GR, Jacquette GM (2012) Prosthetic knee infection in the young immigrant patient-do not forget tuberculosis! J Arthroplast 27(7):1414.e1–1414.e4
Marculescu CE, Berbari EF, Cockerill FR 3rd, Osmon DR (2006) Fungi, mycobacteria, zoonotic and other organisms in prosthetic joint infection. Clin Orthop Relat Res 451:64–72
Marmor M, Parnes N, Dekel S (2004) Tuberculosis infection complicating total knee arthroplasty: report of 3 cases and review of the literature. J Arthroplast 19(3):397–400
Porat MD, Ausin MS (2008) Bilateral knee periprosthetic infection with Mycobacterium fortuitum. J Arthroplast 23(5):787–789
Pring M, Eckhoff DG (1996) Mycobacterium chelonae infection following a total knee arthroplasty. J Arthroplast 11(1):115–116
Spinner RJ, Sexton DJ, Goldner RD, Levin LS (1996) Periprosthetic infections due to Mycobacterium tuberculosis in patients with no prior history of tuberculosis. J Arthroplast 11(2):217–222
Wolfgang GL (1985) Tuberculosis joint infection following total knee arthroplasty. Clin Orthop Relat Res 201:162–166
Parvizi J, Ghanem E, Menashe S, Barrack RL, Bauer TW (2006) Periprosthetic infection: what are the diagnostic challenges? J Bone Joint Surg Am 88(suppl 4):138–147
Insall JN, Dorr LD, Scott RD, Scott WN (1989) Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 248:13–14
Bellamy N (2008) WOMAC osteoarthritis index: a user’s guide IX. The University of Queensland, Brisbane, p 176
Dripps RD, Lamont A, Eckenhoff JE (1961) The role of anesthesia in surgical mortality. JAMA 178:261–266
Ewald FC (1989) The Knee Society total knee arthroplasty roentgenographic evaluation and scoring system. Clin Orthop Relat Res 248:9–12
Watts HG, Lifeso RM (1996) Tuberculosis of bones and joints. J Bone Joint Surg Am 78(2):288–298
Johnson R, Barnes KL, Owen R (1979) Reactivation of tuberculosis after total hip replacement. J Bone Joint Surg (Br) 61:148–150
Krappel FA, Harland U (2000) Failure of osteosynthesis and prosthetic joint infection due to Mycobacterium tuberculosis following a subtrochanteric fracture: a case report and review of the literature. Arch Orthop Trauma Surg 120:470–472
Tokumoto JI, Follansbee SE, Jacobs RA (1995) Prosthetic joint infection due to Mycobacterium tuberculosis: report of three cases. Clin Infect Dis 21(1):134–136
Ueng WN, Shih CH, Hseuh S (1995) Pulmonary tuberculosis as a source of infection after total hip arthroplasty: a report of two cases. Int Orthop 19(1):55–59
Kim YH, Han DY, Park BM (1987) Total hip arthroplasty for tuberculous coxarthrosis. J Bone Joint Surg Am 69(5):718–727
Kim YY, Ahn BH, Bae DK, Ko CU, Lee JD, Kwak BM et al (1986) Arthroplasty using the Charnley prosthesis in old tuberculosis of the hip: clinical experience with 8–10-year follow-up evaluation. Clin Orthop Relat Res 211:116–121
Eskola A, Santavirta S, Konttinen YT, Lindholm ST (1988) Arthroplasty for old tuberculosis of the knee. J Bone Joint Surg (Br) 70(5):767–769
Grosskopf I, Ben David A, Charach G, Hochman I, Pitlik S (1994) Bone and joint tuberculosis-a 10-year review. Isr J Med Sci 30(4):278–283
Lusk RH, Wienke EC, Milligan TW, Albus TE (1995) Tuberculous and foreign-body granulomatous reactions involving a total knee prosthesis. Arthritis Rheum 38(9):1325–1327
Li Q, Pan YX, Zhang CY (1994) Specific detection of Mycobacterium tuberculosis in clinical material by PCR and Southern blot. Zhonghua Jie He He Hu Xi Za Zhi 17(4):238–240 256
Titov AG, Vyshnevskaya EB, Mazurenko SI, Santavirta S, Konttinen YT (2004) Use of polymerase chain reaction to diagnose tuberculous arthritis from joint tissues and synovial fluid. Arch Pathol Lab Med 128(2):205–209
Kumar M, Sharma S, Ram AB, Khan IA (2010) Efficient mycobacterial DNA extraction from clinical samples for early diagnosis of tuberculosis. Int J Tuberc Lung Dis 14(7):847–851
Goldman RT, Scuderi GR, Insall JN (1996) 2-stage reimplantation for infected total knee replacement. Clin Orthop Relat Res 331:118–124
Ha KY, Chung YG, Ryoo SJ (2005) Adherence and biofilm formation of Staphylococcus epidermidis and Mycobacterium tuberculosis on various spinal implants. Spine 30(1):38–43
Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C (2003) Tuberculosis. Lancet 362(9387):887–899
Martin ML, Dall L (1984) Emergence of multidrug-resistant Mycobacterium fortuitum during treatment. Chest 85(3):440–441
Brown-Elliott BA, Wallace RJ Jr (2002) Clinical and taxonomic status of pathogenic nonpigmented or late pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 15(4):716–746
Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ 3rd (1992) Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 36(1):180–184
Dalovisio JR, Pankey GA, Wallace RJ, Jones DB (1981) Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis 3(5):1068–1074
Brown-Elliott BA, Griffith DE, Wallace RJ Jr (2002) Newly described or emerging human species of nontuberculous mycobacteria. Infect Dis Clin N Am 16(1):187–220
Wallace RJ Jr, O’Brien R, Glassroth J (1990) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 142:940–953
Author information
Authors and Affiliations
Contributions
BHH and SCL initiated the study and set up the design. BHH and HSA collected and analyzed data. BHH wrote the manuscript. BHH, AO, and SHM revised every version. All authors reviewed the final manuscript. All authors agreed to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Ethics approval
The authors’ institutional review board approved this study.
Informed consent
Informed consent was obtained by each patient in this study.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Level of evidence: Level IV, retrospective study
Rights and permissions
About this article
Cite this article
Hwang, BH., Lee, SC., Ong, A. et al. Mycobacterial periprosthetic joint infection after primary total knee arthroplasty. International Orthopaedics (SICOT) 45, 3055–3062 (2021). https://doi.org/10.1007/s00264-021-05029-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-021-05029-x